{"id":5103,"date":"2024-01-26T19:56:24","date_gmt":"2024-01-26T18:56:24","guid":{"rendered":"https:\/\/p664637.webspaceconfig.de\/?post_type=izb-biotech-news&p=5103"},"modified":"2026-07-09T12:08:25","modified_gmt":"2026-07-09T10:08:25","slug":"catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb","status":"publish","type":"izb-biotech-news","link":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\/","title":{"rendered":"CatalYm strengthens Board of Directors and Scientific Advisory Board with key appointments"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

Roy Baynes as new member of the Board of Directors and Roy Herbst, Petros Grivas and Andrea Necchi as new members of the SAB will strategically advise CatalYm on the advanced clinical development of the monoclonal antibody visugromab.<\/p>\n","protected":false},"featured_media":5102,"parent":0,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[80,81],"tags":[],"class_list":["post-5103","izb-biotech-news","type-izb-biotech-news","status-publish","format-standard","has-post-thumbnail","hentry","category-izb-news-en","category-izb-biotech-news-en"],"acf":[],"acf_migration":{"izb_related_company":"355"},"wpml_migration":{"language_code":"en","source_language_code":"de","trid":"29127"},"yoast_migration":{"_yoast_wpseo_title":"CatalYm strengthens Board of Directors and Scientific Advisory Board with key appointments - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","_yoast_wpseo_metadesc":"Roy Baynes as new member of the Board of Directors and Roy Herbst, Petros Grivas and Andrea Necchi as new members of the SAB will strategically advise CatalYm on the advanced clinical development of the monoclonal antibody visugromab."},"permalink_migration":{"custom_uri":"izb-biotech-news\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb"},"yoast_head":"\nCatalYm strengthens Board of Directors and Scientific Advisory Board with key appointments - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB<\/title>\n<meta name=\"description\" content=\"Roy Baynes as new member of the Board of Directors and Roy Herbst, Petros Grivas and Andrea Necchi as new members of the SAB will strategically advise CatalYm on the advanced clinical development of the monoclonal antibody visugromab.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CatalYm strengthens Board of Directors and Scientific Advisory Board with key appointments - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" \/>\n<meta property=\"og:description\" content=\"Roy Baynes as new member of the Board of Directors and Roy Herbst, Petros Grivas and Andrea Necchi as new members of the SAB will strategically advise CatalYm on the advanced clinical development of the monoclonal antibody visugromab.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\/\" \/>\n<meta property=\"og:site_name\" content=\"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-09T10:08:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/SCI_Illustrate_5th_600x383-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"383\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\\\/\",\"url\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\\\/\",\"name\":\"CatalYm strengthens Board of Directors and Scientific Advisory Board with key appointments - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/SCI_Illustrate_5th_600x383-1.jpg\",\"datePublished\":\"2024-01-26T18:56:24+00:00\",\"dateModified\":\"2026-07-09T10:08:25+00:00\",\"description\":\"Roy Baynes as new member of the Board of Directors and Roy Herbst, Petros Grivas and Andrea Necchi as new members of the SAB will strategically advise CatalYm on the advanced clinical development of the monoclonal antibody visugromab.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\\\/#primaryimage\",\"url\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/SCI_Illustrate_5th_600x383-1.jpg\",\"contentUrl\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/SCI_Illustrate_5th_600x383-1.jpg\",\"width\":600,\"height\":383,\"caption\":\"Neuartiger Ansatz von CatalYm, um Krebsbehandlungen zu verbessern\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IZB Biotech News\",\"item\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/izb-biotech-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CatalYm strengthens Board of Directors and Scientific Advisory Board with key appointments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/\",\"name\":\"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.\",\"description\":\"Der Ort f\u00fcr Biotech-Start-ups in M\u00fcnchen: Labore, B\u00fcror\u00e4ume, Netzwerk!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CatalYm strengthens Board of Directors and Scientific Advisory Board with key appointments - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","description":"Roy Baynes as new member of the Board of Directors and Roy Herbst, Petros Grivas and Andrea Necchi as new members of the SAB will strategically advise CatalYm on the advanced clinical development of the monoclonal antibody visugromab.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\/","og_locale":"en_US","og_type":"article","og_title":"CatalYm strengthens Board of Directors and Scientific Advisory Board with key appointments - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","og_description":"Roy Baynes as new member of the Board of Directors and Roy Herbst, Petros Grivas and Andrea Necchi as new members of the SAB will strategically advise CatalYm on the advanced clinical development of the monoclonal antibody visugromab.","og_url":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\/","og_site_name":"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.","article_modified_time":"2026-07-09T10:08:25+00:00","og_image":[{"width":600,"height":383,"url":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/SCI_Illustrate_5th_600x383-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\/","url":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\/","name":"CatalYm strengthens Board of Directors and Scientific Advisory Board with key appointments - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","isPartOf":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\/#primaryimage"},"image":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\/#primaryimage"},"thumbnailUrl":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/SCI_Illustrate_5th_600x383-1.jpg","datePublished":"2024-01-26T18:56:24+00:00","dateModified":"2026-07-09T10:08:25+00:00","description":"Roy Baynes as new member of the Board of Directors and Roy Herbst, Petros Grivas and Andrea Necchi as new members of the SAB will strategically advise CatalYm on the advanced clinical development of the monoclonal antibody visugromab.","breadcrumb":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\/#primaryimage","url":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/SCI_Illustrate_5th_600x383-1.jpg","contentUrl":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/SCI_Illustrate_5th_600x383-1.jpg","width":600,"height":383,"caption":"Neuartiger Ansatz von CatalYm, um Krebsbehandlungen zu verbessern"},{"@type":"BreadcrumbList","@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/p664637.webspaceconfig.de\/en\/"},{"@type":"ListItem","position":2,"name":"IZB Biotech News","item":"https:\/\/p664637.webspaceconfig.de\/izb-biotech-news\/"},{"@type":"ListItem","position":3,"name":"CatalYm strengthens Board of Directors and Scientific Advisory Board with key appointments"}]},{"@type":"WebSite","@id":"https:\/\/p664637.webspaceconfig.de\/en\/#website","url":"https:\/\/p664637.webspaceconfig.de\/en\/","name":"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.","description":"Der Ort f\u00fcr Biotech-Start-ups in M\u00fcnchen: Labore, B\u00fcror\u00e4ume, Netzwerk!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/p664637.webspaceconfig.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/izb-biotech-news\/5103","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/izb-biotech-news"}],"about":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/types\/izb-biotech-news"}],"version-history":[{"count":1,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/izb-biotech-news\/5103\/revisions"}],"predecessor-version":[{"id":5104,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/izb-biotech-news\/5103\/revisions\/5104"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/media\/5102"}],"wp:attachment":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/media?parent=5103"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/categories?post=5103"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/tags?post=5103"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}